Global Anti-vascular Endothelial Growth Factor Therapeutics Market Size & Outlook
The anti-vascular endothelial growth factor therapeutics industry worldwide is expected to reach a projected revenue of US$ 12,817.8 million by 2028. A compound annual growth rate of 0.5% is expected of the worldwide anti-vascular endothelial growth factor therapeutics industry from 2022 to 2028.
Revenue, 2021 (US$M)
$12,363.5
Forecast, 2028 (US$M)
$12,817.8
CAGR, 2022 - 2028
0.5%
Report Coverage
Worldwide
Global anti-vascular endothelial growth factor therapeutics market, 2017-2028 (US$M)
Related Markets
Global anti-vascular endothelial growth factor therapeutics market highlights
- The global anti-vascular endothelial growth factor therapeutics market generated a revenue of USD 12,363.5 million in 2021 and is expected to reach USD 12,817.8 million by 2028.
- The market is expected to grow at a CAGR (2022 - 2028) of 0.5% by 2028.
- In terms of segment, eylea accounted for a revenue of USD 8,576.3 million in 2021.
- Beouvu is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, U.S. is expected to register the highest CAGR from 2022 to 2028.
Global data book summary
| Market revenue in 2021 | USD 12,363.5 million |
| Market revenue in 2028 | USD 12,817.8 million |
| Growth rate | 0.5% (CAGR from 2021 to 2028) |
| Largest segment | Eylea |
| Fastest growing segment | Beouvu |
| Historical data covered | 2017 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Eylea, Lucentis, Beouvu |
Other key industry trends
- In terms of revenue, the North America accounted for 64.9% of the global anti-vascular endothelial growth factor therapeutics market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 7,285.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-Vascular Endothelial Growth Factor Therapeutics Market Scope
Anti-vascular endothelial growth factor therapeutics market segmentation & scope
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-related Macular Degeneration
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-related Macular Degeneration
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-related Macular Degeneration
Anti-Vascular Endothelial Growth Factor Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global anti-vascular endothelial growth factor therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-vascular endothelial growth factor therapeutics market will help companies and investors design strategic landscapes.
eylea was the largest segment with a revenue share of 69.37% in 2021. Horizon Databook has segmented the Global anti-vascular endothelial growth factor therapeutics market based on eylea, lucentis, beouvu covering the revenue growth of each sub-segment from 2017 to 2028.
- Global Anti-Vascular Endothelial Growth Factor Therapeutics Product Outlook (Revenue, USD Million, 2017-2028)
- Eylea
- Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
- Age-related Macular Degeneration
- Lucentis
- Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
- Age-related Macular Degeneration
- Beouvu
- Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
- Age-related Macular Degeneration
- Eylea
Reasons to subscribe to Global anti-vascular endothelial growth factor therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global anti-vascular endothelial growth factor therapeutics market databook
-
Our clientele includes a mix of anti-vascular endothelial growth factor therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global anti-vascular endothelial growth factor therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global anti-vascular endothelial growth factor therapeutics market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Global anti-vascular endothelial growth factor therapeutics market statistics, by regions, 2017-2028 (US$M)
Top 10 countries: Anti-vascular endothelial growth factor therapeutics market size, 2021 (USD Million)
Top 10 countries: Anti-vascular endothelial growth factor therapeutics market size, 2021 (USD Million)
Global anti-vascular endothelial growth factor therapeutics market, by region, 2021 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
